Amcor plc

Thank you for standing by. My name is Jael and I will be your conference operator today. At this time, I would like to welcome everyone to the MCOR third quarter 2024 results call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. Thank you. I would now like to turn the conference over to Tracey Whitehead, Head of Investor Relations. You may begin.

Thank you, Operator, and thank you, everyone, for joining AMCOR's fiscal 2023 third quarter earnings call. Joining today is Peter Conicci, Interim Chief Executive Officer, and Michael Casamento, Chief Financial Officer. Before I hand over a few items to note, on our website, amcor.com, Under the investor section, you'll find today's press release and presentation, which we will discuss on this call. Please be aware that we'll also discuss non-GAAP financial measures and related reconciliations can be found in that press release and the presentation. Remarks will also include forward-looking statements that are based on management's current views and assumptions. The second slide in today's presentation lists several factors that could cause future results to be different than current estimates. Reference can also be made to AMCOR's SEC filings, including our statements on Form 10-K and 10-Q for further details. Please note that during the question and answer session, we request that you limit yourself to a single question and then rejoin the queue if you have any additional questions or follow-ups. With that, over to you, PK.

Thank you, Tracey, and thank you to all who have joined us for today's call. Prior to discussing our third quarter performance, I want to spend a few moments recognizing my predecessor, Ron D'Elia, and its many accomplishments at Amcor. In the last few years alone, Ron led us through the transformational acquisition and integration of Bemis, the largest acquisition in the company's history, successfully and safely guided the business through a pandemic and made the difficult and correct decision to divest our business in Russia. And most recently, Ron directed our teams in navigating a particularly challenging economic period. I know I speak for the board, our global management team, and our employees around the world in thanking Ron for his leadership, guidance, and dedication during his 18 years with Amcor and nine years as CEO. I've worked closely with Ron, our board, and the other members of our executive team over many years to help shape and execute our strategy, and I'm honored to take the leadership reins in an interim capacity at this time. Today, Amcor is the established industry leader in our key markets and geographies, has world-class talent and clearly differentiated commercial innovation capabilities, all providing us with multiple opportunities to capture high value growth. Importantly, the business is also well positioned to continue benefiting from the proactive steps taken by our leaders across the company to align the cost base with recent challenging market conditions. The results of those decisive actions were again evident in our third quarter financial performance as we showed strong earnings leverage across the business. Third quarter, year-over-year volume performance also improved on a sequential basis and we expect this trend to continue driving stronger earnings growth as we close fiscal year 24. My role right now is to ensure we stay focused and on track and that we capitalize on the strong position we're in to maintain momentum and further accelerate earnings growth. It is a team effort and will drive success and I'm surrounded and supported by credible leaders and talented team players throughout our organization. As seen on slide three, my near-term priorities are simple. First, ensure UMPR continues to provide a safe and healthy work environment for our global workforce. Second, stay close to our key stakeholders, including our employees and customers, and finish our 2024 fiscal year strongly. After an improved third quarter performance, we are well positioned to do so, and we've raised our full year guidance today. Third, built on the momentum we have worked hard to deliver across the business, And as we work through our planning cycle for fiscal 25, set clear priorities to ensure our momentum continues. And fourth, provide stability for the business and keep our teams focused on delivering for all our stakeholders by reinforcing that our strategy has not changed, our agenda has not changed, and our priorities have not changed. Moving to AMGOR's Q3 performance, starting with safety on slide four. Our commitment to health and safety of our teams remains our number one priority, and we continue to focus on providing a safe and healthy work environment. Seventy-two percent of our sites have been injury-free for the past 12 months or longer, and we've experienced a 19 percent reduction in injuries compared to the first nine months of fiscal 23. Safety is deeply embedded in UMGUR's culture and is a critical cornerstone of our success. Turning to our key messages for today on slide five. First, outperformance in the underlying business resulted in adjusted earnings per share for the third quarter that exceeded the expectations we set out in February. Our flexible and rigid packaging segment each delivered adjusted EBIT growth, leading to UMCO returning to year-over-year earnings growth a quarter sooner than we anticipated. Improved working capital performance through the year also resulted in a year-to-date increase in adjusted free cash flow. As I mentioned earlier, our third quarter volume trajectory improved significantly on a sequential basis as destocking abated across most end markets, and we experienced higher customer demand in several of our businesses. While this is clearly an encouraging and positive trend, our teams remained highly focused on continuing to control cost, and this helped us deliver a third consecutive quarter of improved earnings leverage and a return to earnings growth. Third, our March quarter financial performance and expected further momentum in our fourth quarter gives us the confidence to increase our full year adjusted EPS guidance range to 68.5 to 71 cents per share and reaffirm our guidance for adjusted free cash flow between 850 and 950 million dollars for the fiscal year. We believe we have turned the corner after a challenging calendar 2023, and we expect our sequential volume and earnings growth trajectories will continue to improve. which is supported by the demand trends experienced across the business in the first weeks of April. Finally, we remain confident in our capital allocation framework and strategy for long-term growth. We believe the strength of our market positions, our opportunities for investment, and our execution capabilities, along with our commitment to a compelling and growing dividend, make a convincing investment case for Amcor. Moving to slide six for a summary of our financial results. The first nine months of fiscal 24 continue to reflect significant benefits from our proactive cost actions. Three consecutive quarters of strong operating leverage helped offset the unfavorable impact of 7% lower sales, lower year-to-date sales, leading to a decline in adjusted EBIT of 3%. We believe we've reached an inflection point in the trajectory of earnings and volumes with our Q3 results, and we are pleased with our financial results in the March quarter. Better than anticipated demand trends and continued strong cost performance resulted in EBIT and earnings per share ahead of our expectations entering the quarter. The underlying business saw a return to profit growth in the third quarter with adjusted EBIT up 3% compared with last year. Volume trends improved as the broad-based destocking experienced in the December quarter abated and customer demand strengthened. Our teams also continue to focus on cost reduction and productivity initiatives and delivered another quarter of outstanding results with approximately $130 million in total cost savings, including approximately $15 million of benefits from structural cost initiatives. These benefits, combined with improving volume trends, resulted in another quarter of improved earnings leverage. Interest and tax expense were modestly higher than the prior year. in line with our expectations, and adjusted earnings per share of 17.8 cents grew by 1%. Q3 net sales were down 6% on a comparable constant currency basis, which primarily reflects overall volumes 4% lower than the prior year. This is predominantly related to expected ongoing weakness, including further stocking in healthcare categories and in the North American beverage business, which collectively represent approximately 30% of AMGRO's total sales. Across the remaining 70% of our business, overall net volumes were relatively flat with last year, a significant improvement compared with the December quarter, and the business delivered volume growth across several categories and geographies. Outside of healthcare, we believe destocking is now largely behind us. Price mix for Q3 had an unfavorable impact on sales of approximately 3%, which is a result of greater volume declines in high-margin healthcare categories, which we anticipated and called out last quarter. We continue to return significant cash to shareholders through a compelling and growing dividend and share repurchases, which totaled approximately $570 million through the first nine months of the year. I'll turn it over to Michael now to provide some further color on the financials and our outlook.

Thanks, PK, and hello, everyone. Beginning with the flexible segment on slide seven and focusing on our Q3 performance. Net sales for Q3 were down 6%, reflecting an unfavorable price mix impact of 4% and a 2% decline in overall volumes, which was a significant improvement of 8 percentage points compared with the December quarter. As we anticipated and call out last quarter, volumes for healthcare products remained weak and destocking continued, particularly in North America and Europe. In total, healthcare volumes were down double digits, and this had an unfavorable impact of approximately 3% on overall segment volumes, and was the primary driver of the 4% unfavorable mix in the quarter. Across the balance of our Flexibles portfolio, net volumes grew approximately 1% in the quarter, with growth in several end markets including meat, pet food, cheese, and unconverted film and foil. And we also saw growth across a number of emerging markets. Across North America and Europe, third quarter net sales declined at high single digit rates, unfavorably impacted by, pardon me, mid single digit lower volumes and unfavorable price mix related to declines in healthcare categories. Excluding healthcare, across these two regions we saw mid single digit volume growth in cheese and a strong sequential improvement in meat and pet care volumes which were flat and up low single digits for the quarter respectively. Across the Asian region, net sales were modestly higher than the prior year. China grew volumes for the third consecutive quarter. and volume growth in Thailand, India, and the Philippines also helped offset lower volumes in Southeast Asian healthcare business. In Latin America, the business delivered good volume growth in Brazil, Mexico, and Peru. Q3 adjusted EBIT of $358 million was 5% higher than last year on a comparable constant currency basis. Strong cost performance through the quarter, including from restructuring initiatives, combined with broadly improving demand trends, led to another quarter of strong earnings leverage and EBIT margins increased by 170 basis points to 13.8%. Turning to rigid packaging on slide 8, Q3 net sales were 8% lower on a comparable constant currency basis, mainly reflecting lower volumes. While overall volumes were down 8% for the quarter, this represents a meaningful improvement over the December quarter. In North America, overall beverage volumes continue to be impacted by soft consumer and customer demand in AMCOR's key end markets, along with some lingering destocking. Total beverage volumes were down 11%, improving sequentially from the 19% decline we experienced in December quarter, which was impacted by significantly more destocking. Latin American volumes were in line with last year with growth in Brazil and Colombia, offset by weaker demand in Argentina. We are pleased to see the rigid packaging business return to earnings growth with adjusted third quarter EBIT up modestly over last year. Strong earnings leverage resulting from a continued focus on cost reduction and productivity measures and the realization of benefits from restructuring initiatives more than offset lower volumes leading to an 80 basis point increase in EBIT margins to 8.7% for the quarter. Moving to cash and the balance sheet on slide nine. Adjusted free cash flow for the first nine months was approximately $100 million ahead of last year, mainly driven by improved working capital performance and successfully reducing inventory levels for the fifth consecutive quarter. Leverage at 3.4 times was broadly in line with the first half and within the range of expected outcomes for the third quarter. As a reminder, the business is cycling through temporary increases in working capital and trailing 12-month EBITDA remains at lower than historic levels, reflecting the divestiture of our Russian business in December 2022. Looking ahead, we continue to expect leverage will decrease to approximately three times at the end of our fiscal year, supported by seasonally stronger earnings and cash flow in our fiscal fourth quarter. This brings me to our outlook on slide 10. As PK noted earlier, we are raising our full year guidance for adjusted EPS to 68.5 to 71 cents per share to reflect our performance in the underlying business in the third quarter and our expectation that volumes will continue to improve through the balance of the year. We also remain focused on controlling costs and expect to deliver further savings in Q4, including from our structural initiatives. For fiscal 2024, we continue to expect the underlying business to contribute organic earnings growth in the plus or minus low single digit range with share repurchases adding a benefit of approximately 2% and favourable currency translation contributing a benefit of up to 2%. This is offset by a negative impact of approximately 3% related to the sale of our Russian business in December 2022, the impact of which was all in the first half. We also expect a negative impact of up to 6% from higher interest and tax expense. which takes into account our updated estimate for the full year net interest expense of between $310 to $320 million. We are confident we will build on our third quarter performance and adjusted earnings per share for the fourth quarter is expected to grow over last year by mid single digits on a comparable constant currency basis. And overall volumes in the fourth quarter are expected to be down in the low single digit range, primarily due to ongoing destocking in healthcare categories and continued weak consumer and customer demand in North American beverage. We expect the volume improvement we experienced in the third quarter to continue as we progress through the fourth quarter, which will position us well as we enter fiscal 2025. We have also reaffirmed our guidance range for adjusted free cash flow of $850 million to $950 million for the year. So with that, I'll hand back to PK.

Thank you, Michael. In closing on slide 11, our Q3 financial results Guidance for the balance of the fiscal year and our expectation that we will continue to build earnings momentum in fiscal 25 all highlight that Amgur is a very well-positioned business. Amgur's industry leadership across the globe is well-established. Our differentiated innovation capabilities are assisting the world's best-known brands and smaller companies in achieving their objectives to protect, preserve, and promote their products while enabling them to meet the sustainability commitments they have made to their stakeholders. And UMCOR's talent and employees around the world are capitalizing on growth opportunities in priority categories, emerging markets, and through sustainable offerings while also continuing to closely focus on cost controls. We're confident we will continue to see positive momentum given the actions we have taken and continue to take across our operations to invest in growth, reduce cost, and improve productivity. As I mentioned at the beginning of the call, my role right now is to ensure we stay focused and on track, and that we capitalize on the strong position we are in to maintain momentum and further accelerate earnings growth. The continued safety of our people will always be at the top of Amcor's agenda, but a very close second for me right now is to keep our teams focused on delivering for all our stakeholders by reinforcing that our strategy, our agenda, and our priorities have not changed. Our Q3 volume trajectory and financial performance underscores our confidence in stronger earnings growth momentum as the challenges we faced in calendar 23 are put further behind us. We have raised our full-year EPS guidance, and we anticipate delivering mid-single-digit earnings growth in Q4. Our performance in the first few weeks of April supports this expectation, and our commitment to our longer-term growth and value creation strategy gives us line of sight to return to growth in line with our shareholder value creation model. Operator, we're now ready to turn the line over to questions.

Thank you. The floor is now open for questions. If you have dialed in and would like to ask a question, please press star 1 on your telephone keypad to raise your hand and join the queue. If you would like to withdraw your question, simply press star 1 again. If you are called upon to ask a question and are listening via loudspeaker on your device, please pick up your handset to ensure that your phone is not on mute when asking your question. In the interest of time, We would like to remind participants to limit their questions to one and to rejoin the queue for any follow-ups. The first question comes from the line of Gansham Panjabi of Baird. Your line is open.

Hey, guys. How are you? I guess first off, you know, it just sounds like volume surprised you to the upside during your third quarter. Do you think that's just a function of 2Q coming in lower than forecast just given aggressive, you know, year-end inventory stocking by your customers? Or do you think this is more of a sustainable improvement that you're going to build upon as you look out to your fiscal year 25? Thanks.

Yeah, thanks. It's a great question. I mean, there's a couple of things to take away here from the discussion of the quarter. The first one really is that volumes improved. The second one is that we had great cost performance. And the third one really is that we believe the momentum carries over into the Q4. But let me get back to the volume question. So significant improvement sequentially on the volumes from the second to the third quarter. To remind ourselves, second quarter we were down 10%, third quarter we were coming in 4% down versus prior year. And when you look at the 4% that we were down, it pretty much equally splits between two drivers. That's the market impact, and by that I mean consumer demand and our exposure to categories and customers. And then the second one is destocking. So that made up the 4% decline. And another way to look at that is the 4% decline was pretty much all driven by destocking in healthcare and North American beverage. That also means that the balance of the portfolio ended up being pretty flat. And we were pretty much pleased with this outcome because when you think about it, healthcare and North American beverage is about 30% of our business. That means the balance of the portfolio, 70% came in flat. Now, when I take a step back and we look at the third quarter volume performance, there's a few things that we take away. The first one is we saw a bit of unwind of a very strong stocking in the December month. And when, you know, we discussed the second quarter, we talked about a pretty strong January, and there was a bit of a question mark around how much of that performance was driven by unwind of the December month. And as we sort of left Q3 behind us, we can confirm that the volumes in January and also February, to a certain extent, benefited from a bit of an unwind in an unusually low December month. So that was the first one. But the second thing that we've seen is that our customers perform better. And we talked about that also in the last quarter. The background here is that customers are, particularly large customers, are talking more and more and responding more and more towards turning the dial a bit towards a better sort of balance between volumes and margins. So we've seen that come through. And then the third one is pretty much what we expected to a certain extent, that the destocking would abate. And that pretty much happened with the exception of healthcare and some lingering destocking in North American beverage. So, look, that's pretty much the discussion of the third quarter. But as I have the floor and volumes, let me just make two more comments in breaking it down into the segments here, because I think the color is important. In flexibles, We came from being 10% down in the second quarter to being 2% down in the third quarter. And again, you know, the customer performance sort of drove improved market impact performance. And then the stocking significantly abated. And when you look at the flexible segment, it was all made up by the healthcare impact. In terms of the decline, the balance of the portfolio is flat to even slightly up. And then just one more comment on rigids, and then I'll stop. Rigids went from 12% down in the second quarter to 8% down in the third quarter, so also an improvement. We continue to see a soft market, but the destocking has significantly abated in rigids also. So across the board, really, really good improvement. And when you think back to what I discussed There's components in there that we believe to be sustainable, no question. And that relates to one, further abatement of the destocking, and second, to good customer performance that we believe we will continue to see also in Q4.

Your next question comes from the line of Daniel Kang of CLSA. Your line is open.

Good morning, PK. Good morning, Michael. Just a question on health care. You mentioned health care continues to fall double digits in 3Q, which from memory sounds quite similar to the December quarter. Can you comment on whether there was any sequential improvement in 3Q? And just from your visibility of customer stock levels and given the low comps that we should be working with going forward, Is it reasonable to expect that first half fiscal year 25 to show some improvement in health care bonds?

Let me help you with health care a bit. So the main driver of the health care performance really has been the stocking and the stocking sort of abating from Q2 to Q3. I would say overall the demand situation has not really changed much in healthcare. So you would see overall healthcare is marginally better between the second and the third quarter. We do expect further improvement in healthcare though because the stocking will further sort of reduce in the fourth quarter. As a matter of fact, when we guide to low single digits volume decline in the fourth quarter, we would believe that most of that is driven by healthcare. All of that is driven by healthcare. And, you know, we don't really know exactly when the destocking will come to an end. It will certainly sort of stretch into the fourth quarter. Maybe we'll see a bit of an, we see a bit of an impact also in the first quarter of fiscal 25. But that would be as far as I would go with everything that I know at this point in time. Maybe one more thing that I would want to add, too, is that, you know, again, we're talking about low single digits decline on volumes in the fourth quarter, but with a further improving trajectory. And we're expecting to exit the fourth quarter flat on volumes.

Your next question comes from the line of Adam Samuelson of Goldman Sachs. Your line is open.

Yes, thank you. Good afternoon, everyone. I was hoping to maybe talk a little bit about the operating leverage in the business or lack thereof on the deleverage side, just given the profit performance, especially in flexibles relative to the volume and mixed declines you still saw in the period. I'm hoping to maybe just aggregate a little bit the amount of fixed cost reductions actually realized in the period versus the variable cost kind of efficiencies and productivity gains in the quarter and how kind of durable you think those variable costs and productivity improvements prove to be if volumes start to normalize or how much costs would have to leak into the system to serve incremental volumes from here.

Thanks for the question, Adam. I'll take that. It's Michael here. Look, on the cost side, we're really pleased with the cost performance of the business in Q3. We took another $130 million out of cost, which included some benefit from the restructuring program that we've got in place. So we are now starting to see that come through. So that was about $15 million as expected. And if you just take a step back and think about the cost work we've been doing, what are we actually doing? There's two things that we're focused on. Firstly, you know, the operational side of the business, so cost productivity and cost flexing in a lower volume environment. And then the second is that structural program that we've talked about, you know, in response to try and offset some of the vested Russia earnings. So, you know, in the quarter, we saw benefits from both and we saw that in both the flexibles and rigid segment as well. So that was pleasing. And look, on the operational side, what have we been doing? We've been really both proactive and aggressive in flexing the cost base. And that's taking into account the lower demand environment. So we've been certainly eliminating shifts to take labor out where we can, reducing the overtime to take that labor cost out. you know, taking extended shots, you know, when we're aligning with some of our customers so we can take extended shots over long weekends and other things to get the plants fully closed and get the cost out that way. You know, we're driving procurement, you know, obviously in a low volume environment, that's also an opportunity for us to drive procurement savings and we've been really focused on that and the team's done really good work there. And we've been, you know, tightly controlling our discretionary spend. You know, that's kind of on the operating side. And then on the structural side, you know, that's more about plant closures. So we've announced seven plant closures and two restructures. And more recently, we've actually completed the closure around three or four of those. You know, so we've now started to see that benefit flow through as we anticipated. And that program was going to deliver about a 50 million EBIT benefit over the program. $35 million predominantly in the second half of FY24 and then another $15 million into FY25. And, you know, we're pleased to report that we are now seeing those benefits come through. And in Q3, that contributed $15 million. The majority of that was in flexibles, but also a few million in rigids. So, again, good cost control in both of those areas. And, you know, it's difficult to determine how much of that is going to stick with the business long term. But I guess what we would say is that you know, we've taken a pretty significant headcount out of the business. You know, if you think about the structural cost out, I mean, those structural costs that come out and they're permanent. So the $50 million over time that comes through will be permanent. I mean, on the procurement benefits, they'll be sustained. You know, the productivity we anticipate, you know, over the last several quarters, we've improved productivity, improved efficiency, being able to do more with less. So again, we'd expect that to continue. But as the volumes come back, we will have to put labor back into the business, rebuild shifts, but it's not going to be linear. So we expect that we will continue to see margin improvement. And this will just contribute to AMCOR's ongoing margin enhancement. We typically, over a long period of time, have added 20 to 30 basis points in margin a year. And this program, you know, we'd expect to continue that through the cost measures that we've taken here. And, you know, you saw that in the quarter. I mean, we delivered 120 basis point increase on the back of volumes improving, but, you know, cost takeout really strong and the performance there across the business was great. So, you know, we feel pretty good about where we're at. There's still more costs to come out. You'll see further benefits from the structural programs in Q4, as well as some ongoing efficiency benefits from the actions we've already taken.

Michael, I would add that we're particularly pleased with the work that's been done in the rigid segments here, because we acknowledge that the business returned back to profit growth in the third quarter on the back of a pretty soft environment still. So that speaks to good leverage in that business.

Your next question comes from the line of John Patel of Macquarie. Your line is open.

Good afternoon, Peter and Michael. I'll just ask my one. The sequential volume pickup in flexibles, just from the commentary in the release, that appeared to mainly come from emerging markets rather than developed markets. So was there much sequential volume improvement in North America and Europe, for example?

Yeah, that's also a great question. So in terms of our country sort of performance or the different regions, you're right. We saw no single-digit growth in emerging markets in the third quarter, which was obviously pleasing and positive. On the developed markets, we saw bigger sequential improvement while we were still negative. in terms of our volume performance versus prior year. Now, you know, you got to keep in mind that the bigger markets were the ones that were more heavily hit with inventory builds and now with the normalization, therefore the destocking. And that would also make sense particularly with our exposure to healthcare in those markets.

Your next question comes from the line of Richard Johnson of Jefferies. Your line is open.

Thanks very much. PK, I think I'm right in saying you've pretty much worked in every part of the business except rigids. I'd be really interested just to get a sense of how you feel about the strategic positioning of the group overall at the moment, but also particularly focusing on rigid plastics, which is perhaps in a slightly different position, and with a backdrop of, in the beverage market anyway, other substrates appearing to be recovering a lot quicker than plastics.

Yeah, Richard, thanks for the question. I mean, there is, you know, we're in a particular situation right now with the business. We've had a couple of tough quarters behind us with volume weakness. And we've worked really hard to position the business as well as possible to take advantage of the volumes improving again. And we believe that's exactly the situation we're in right now. So, you know, we said in discussing, after discussing the second quarter, we said we feel like the second quarter for the business was the low point. And, you know, particularly now as we're having the third quarter an hour back, I think we can confirm that. That's where we stand, and we believe that we will see a better volume performance in Q4. So that's the starting point. In that environment, you know, we felt we want to get, first of all, back to the earnings capacity of the businesses that we have without asking strategic questions. about the businesses and we believe particularly to rigid plastics. You're right, I've been around in Amcor a bit, rigid plastics I've not managed myself. But when we look at rigid plastics, we think it's a good business strategically. And I'll give you a couple of views here from my side. First of all, it's a scale business. It's an important business for Amcor. There's no question about it. And secondly, when you look at the portfolio of the business, it's actually a number of different businesses under one roof. Often we focus very strongly on discussing North American beverage, but it's more than that. We have a specialty containers business, so we've started to diversify. We have a Latin American business, and we have a closures business with our BCNA business. So it's a portfolio of businesses. We have really good industry positions across regions where we participate. We like the customer relationships that we have. We have good, solid customer relationships. And on top of that, also in the overall context of plastic, we have a strong sustainability profile. particularly in that business, which is really important. And finally, I'll come back to what I said at the beginning. We've done a lot of strengthening in the business and the restructuring. For example, with the footprint optimization that we've gone through and we've generated a leverage that has enabled us to return the business back to profit growth. So I think, you know, where we stand right now is we want to see the volumes come back and then we want to see what the business can deliver. There's no question that we want the business to deliver more. And that's where I would leave it for now. By the way, I think, I don't know if you said it's the rigid plastics business or the rigid packaging business. Actually, we call it the rigid packaging business. And it's just a little clarification. Thank you.

Your next question comes from the line of James Wilson of Guardian Australia. Your line is open.

James Wilson Hi, guys. Good morning. Would you be able to just talk us through the net interest guidance that you guys have put out, particularly what's driving the lower net interest, given that leverage looks unchanged in your guidance? I understand that you've had some working capital improvements, but are there anything else that's driving that?

Yeah, thanks for the question. You saw us, we reduced slightly the guidance. Our guidance prior to this quarter was $315 million to $330 million, and we reduced that down to $310 million to $320 million. And look, that's really just on the back of the timing of the cash flows and the working capital improvements. We saw a little better timing of cash coming into the business, which as we look at the forecast for the fourth quarter, you know, we can see that phasing and see that there's a little bit of upside there on the interest costs. So, you know, we adjusted the guidance range accordingly, but outside of that, there's not a lot of, no real change in the rate profile or, you know, the mix of debt.

Your next question comes from the line of George Paphos of Bank of America. Your line is open.

Good afternoon. Thanks for taking my question. PK, could you give us a bit more color in terms of some of the trends you're seeing in flexible in cheese and protein and some of the other key markets? And relatedly, are you seeing your customers perhaps pushing back some of their sustainability targets, a la one of the larger branded companies? And what are the implications for you in terms of growth as well? Thank you.

Sure. So in flexibles, again, pretty significant improvement in volumes between Q2 and Q3. I did make a comment earlier, you know, in terms of the two main drivers here, market impact. We pretty much were flat in the third quarter, and the destocking sort of went down. to low single digits. And it pretty much is the healthcare impact of the stocking that drove the volume decline versus prior year. And the balance of the portfolio is pretty much flat to slightly growing. Now, in terms of the category performance against that, you would remember that we're driving a couple of priority categories here in the business where we believe we have really differentiated products and a good position in the market and where we like the market dynamics. And those would be, you know, health care, meat, you have heard us talk to that, protein, protein breaks out in cheese and meat. Hot fill beverage obviously would be one, pet food, premium coffee. And those are really the five focus categories that we drive. And we have seen, particularly in pet care, meat and cheese, we have seen growth in the quarter, which we're pleased with. Now, I will say, you know, these are green shoots, and don't walk away from the call believing that this is like significant growth numbers. These would be low single digits, so we got to stay bolted here. But we like what we see, and we'd love to see a little more. Maybe a little more color here on seas, as you particularly asked, in North America and Europe, we would be up also on the basis of less de-stocking meat, also less de-stocking and some regional winds that we've seen. Yeah, sorry, sorry, sorry, sorry. I just want to take the other part of the question, which was just check my notes here on the sustainability side and targets being pushed out and the effect on our business. Look, we follow the discussions closely. Actually, we are part of the conversations. And, of course, we noticed that some industry participants have started to think about resetting their targets for their sustainability. initiatives you know at the end of the day we're talking about essentially putting circularity in place a circular economy for for for plastic which will which will be the critical initiative to keep plastic waste out of the environment and that requires a lot of things that have to come together we're going to have to work together nobody can do that alone and I think the understanding in the industry right now is after having worked very closely on the topic that it may take a little more time to get to the targets that we've set years ago. I mean, I don't know if you particularly think about Unilever who's come out with pushing the targets backwards. but they were the first ones to come out and make a commitment and that was sort of in 2017 if I have that correctly in my in my mind and over the years they have learned a lot the industry has learned a lot so I think it's it's a it's a matter of additional realism to just simply to they're saying now in terms of in terms of Amcor We have made a pledge in 2018. We're the first packaging company out there to pledge that we'll make 100% of our packaging recyclable, reusable, or compostable by 2025. And we're pretty much around the corner. We do not have the need to push our targets out at this point in time. We're making really good progress because we have, at this point in time, roughly 90% of our packaging portfolio in recycle-ready structures. We have those alternatives available, and we're ready to sell them to customers when they want them. So everybody needs to do their piece. We're holding on to our targets right now. We don't think that it means anything to us that others are pushing their targets out. We're very committed to our sustainability targets, like the industry is, particularly our big customers are particularly Unilever is. So we continue to drive that with full force.

Your next question comes from the line of Brooke Campbell of Bear and Joy. Your line is open.

Yeah, good evening. Thanks for taking my question. Just with respect to trajectory in the business, this financial year has been better than expected. The third quarter you saw some EPS growth versus back in Feb. The expectation was for the third quarter to be down a bit at EPS. Despite this, you've kept your fourth quarter EPS growth at mid-single digits, which is unchanged. So my question really is, why wouldn't the better performance for the first three quarters continue into the fourth quarter? Any reasons what's holding you back from upgrading that fourth quarter expectation would be great, thanks.

Yeah, thanks, Brooke. It's Michael here. I can take that one for you. So, yeah, look, we finished Q3 with EPS growth, which was really pleasing. And, you know, that was on the back of a couple of things. Slightly better volumes really coming out of that December period, you know, as PK touched on earlier. When we worked our way through January, you know, clearly we saw an improved performance and, you know, some of that was relating to some of the unwind out of December. We weren't 100% sure on how that might translate for the rest of the quarter. And what we saw in February was some more unwind clearly from December, which helped improve the performance in the March quarter and led to us being able to deliver EPS growth, which was really pleasing. So you've seen us increase the four-year guidance. We've taken the four-year guidance to 68.5, 71 cents, so an increase there. That's really on the back of that improved performance in Q3. In Q4, we're still expecting sequential improvement, both in volumes and profit. Clearly, the drivers of that, we're going to see that sequential improvement in the volume really held back by the continued destocking in healthcare. That's really the key point that's holding the volumes back in Q4, as PK touched on. That in itself has some unfavorable mix, which we've talked to in the past. So that will continue into Q4, all those start to abate. And certainly the unfavorable mix from healthcare will unwind as volumes start to normalize into the future there. But Q4, still expecting good cost out, good leverage through the P&L from that cost initiative as well as the structural piece adding through there. And we're also expecting... the earnings trajectory to improve to that mid-single digit. We get benefits from the Q4, the absorption in Q4, which is seasonally our biggest quarter as well. So we feel pretty good about where the outlook is for Q4. We have confidence in delivering within that range. What we've seen in the early parts of April confirmed the volume outlook, so we feel confident there. We just felt that we didn't need to get ahead of ourselves at this point in time. Clearly, we've given you a range. We've given the market a range, so that's a reasonable range in Q4. If the volumes come in a little better than what we're expecting, then clearly that's one way that the outcome for the full year could get towards the upper end of the range, along with cost and let's see where raw materials impact as well. Overall, I'd say we feel pretty good about where we've landed in Q3 and what's ahead of us in Q4 to deliver a good year.

Your next question comes from the line of Keith Chow of MST. Your line is open.

Good afternoon, Peter and Michael. Peter, a question just around the PPWR that was voted into European Parliament earlier this month. Can you give us a sense of you know, what ANCOR is planning with respect to any changes to the regulation around plastics in the European Union. I know there's, you know, some impacts that are expected to, you know, be, I guess, a headwind for the plastics industry in Europe by 2030. But just be keen to hear your views on, you know, whether you think there is a headwind for the ANCOR Flexibles business. and if there are any mitigation strategies that are being put in place or whether ANCL is planning ahead to mitigate those headwinds.

Thank you. It's also a great question and obviously falls into our sustainability strategy. Look, I'll start out by saying that we're very supportive of regulatory and legislative developments that sort of drive the whole industry to this circular economy for plastic. And as such, the PPWR is actually welcomed by Amcor and from Amcor because I think we're creating an environment that allows us and the whole industry to make more progress into that direction. Again, everybody has a role to play. We're sitting in the value chain at pretty much the start. Our job is to come up with structures for plastic packaging that are recycle ready, that can be recycled. And I said a little earlier that we're making really good progress in hitting our targets by the end of 2025. So when customers want to have these these structures were ready to provide them to the extent we're not doing that already today, right? So these many of the recycling ready structures are commercial. And by creating a regulatory environment, everybody gets level set. And we can work with certainty in certain directions in order to support the business. and help the very efficient and high-performing packaging substrate find its place also in the context of sustainability. I mean, there is a place for plastic here, and we've got to remind ourselves why we have so much plastic packaging. It's because it's a very efficient and high-performing substrate. The challenge is end-of-life. The circular economy addresses that, and regulation that gets us into that direction is welcome.

Your next question comes from the line of Cameron McDonald of ANP. Your line is open.

Good morning. Question for Michael, if I can, just going back to the interest rate guidance. Can you remind us of what your hedging profile actually looks like? There was obviously last year you had some significant interest rate exposure and my understanding is that that was mainly due to hedging and the exposure to floating rates. So as interest rate expectations have been rather volatile in the last month or so. How do we think about your hedging profile and the exposure to that changing interest rate environment into FY25, please?

Yeah, sure. I think, look, the first place we should start, you know, the debt profile today is about 70% fixed, 30% floating. You know, with that, we have no maturities coming off you know, now until the middle of 2025. So from that respect, you know, we've got a bit of flexibility in how we can manage the debt book and the interest exposure. You know, as you look forward, you know, we haven't provided any guidance for FY25, but clearly we've given you some guidance for 24. If you look at our debt profile and then you look at some of the forward curves over the next 12 months or so, You know, we're not expecting a material movement in our interest expense just based on the debt profile we have and the maturities that we've got coming. So we've got some flexibility to work through how we manage that debt book and that currency exposure as well. So when you put all that together, we don't see any material change or impact on the interest expense as we look forward into 2025. But we'll provide you further guidance on that in August when we provide the full year guidance for FY25 at that time.

Your next question comes from the line of Anthony Longo of JP Morgan. Your line is open.

Good evening, Pete. Good evening, Michael. Just a quick one on restocking. You've spoken about that a fair bit already. But how are you ultimately thinking about the restocking cycle in light of That's some of the early positive customer discussions that you have had to date. And ultimately, what does that inform the top-line growth expectations from here? I appreciate there's no guidance, but just how are you thinking about that and philosophies around your customers' inventory management from here as well?

Yeah, look, I'll start, and then maybe Michael wants to build on it. You know, the way that we look at this is, you know, the destocking that we're seeing currently is really a correction. of the industry of holding too much inventory after a pretty volatile environment, which was driven by partly supply chain shocks that we've seen in the industry sort of, you know, de-risking and protecting their top line by building inventory. And then there are other reasons. But anyway, what we're seeing right now is that the industry is normalizing across the categories. We see healthcare a little bit delayed because that's a very conservative industry, and they probably built more because of the dynamics over the last couple of years, and now they're starting to be confident again in the environment so that they can also reduce their inventory levels again to a normal level. Now, the new normal is probably different from what it was before, holding cost of inventories because of interest rates. drive that down further. The industry is looking at new efficiency levels in terms of running inventories, and that's what we're going through right now. Going forward, we will see changes in inventory, but those will be tactical or they will go along with the seasonality of the business. So I would not think about it as there is a trend to restocking you know, industries coming down to a new normal and everything that we see from there is going to be tactical or following the seasonality of the different businesses. So that's how I think about it. And therefore, you know, once we have this extraordinary impact behind us, we will see, you know, with our category and customer exposure and then also hopefully going forward also a renewed and stronger consumer interest and demand, we will see top-line growth.

Operator, we have time for one more question, please.

Thank you. Your last question comes from the line of Andrew Scott of Morgan Stanley. Your line is open.

Thank you. Michael, just a question for you. Forty-odd million dollars of below-the-line items there. I see the restructuring charges up relative to last quarter. Can you talk to us just two things, cash versus non-cash there, and when do we get line of sight to maybe seeing an end to these below the line items?

Look, Andrew, the main items in the quarter are really around the restructuring program, which we've had in there for the last 12 months or so. That program is pretty much two-thirds of the way through. We've now started to see the benefits come through from that program. You might remember we committed to invest around $170 million in cash. We've spent on that program to date about $110 million, so we've still got $50 to $60 million to go. But we are starting to see the benefits come through from that, so we're pretty pleased about the progress. And really, by the end of the calendar year, we'd expect to be most of the way through that program. That's the way we see it from there. And as I said, we're pleased that we're now getting the benefits. The $15 million in the quarter came through, and we'll expect to build on that in quarter four and then into 25. So pretty pleased with where the program's at, and it's on track.

Ladies and gentlemen, this concludes our question and answer session. I will now turn the call back to management for closing remarks.

Yeah, thank you, operator. Look, thank you everybody for the interest in the company. You know, the only thing that I want to say here before we close the call is we're pretty pleased with the way how the Q3 turned out for us. I hope we were able to demonstrate that, you know, this was based on a broad-based volume improvement that we've seen in the business combined with really some good cost performance in the third quarter. That also has impacted our margin performance, and more importantly, we believe that we have some underlying momentum here in order to, that will carry into Q4. So, we're very pleased with the situation we're in. We're going to take advantage of the momentum, and with that, we're going to close the call, and we're going to talk to each other again at the end of the fiscal year. Thank you very much.

This concludes today's conference call. You may now disconnect.